Be a VIP (Vaccinated, Immunized Person)! Besides the obvious health aspects of getting a COVID-19 shot, a number of companies are offering incentives to those who can show proof they have received their coronavirus vaccine.
Vaccine Tracker According to the CDC, as of 4/27/2021, a total of 297 million doses have been delivered and 232 million doses have been administered. This accounts for; 29.1% of the total population, 37.3% of those over 18 years of age and 67.9% of those over 65 years of age being fully vaccinated. Updated CDC Mask Guidelines Excerpts from the newly updated CDC recommendations for fully vaccinated people. Fully vaccinated: People no longer need to wear a mask outdoors, except in certain crowded settings and venues Asymptomatic workers no longer need to be restricted from work following an exposure People can visit other fully vaccinated people indoors without masks or physical distancing An individual is considered fully vaccinated ≥2 weeks after they have received the second dose in a 2-dose series shot or ≥2 weeks after they have received a single-dose vaccine. Summer Camp During the Pandemic On 4/24/2021, the CDC updated their recommendations for children attending summer camp. They include campers staying at least 3 feet apart from each other most of the time and 6 feet of social distancing for children while eating and drinking. Camp counselors and adults present should stay at least 6 feet away from each other and children. Summer camps should have most of their activities outdoors. If they do activities indoors, they should leave windows and doors open. The CDC is encouraging camp employees over the age of 16 to get vaccinated as soon as possible. Masks are still recommended for anyone who can wear one except when doing activities that preclude mask-wearing, such as eating and drinking or swimming. The full guidance includes other strategies that camp programs can use to maintain healthy operations, lower the risk of COVID-19 in their programs, prepare for when someone is sick, and support coping and resilience. Vaccine Updates Johnson & Johnson – The FDA and CDC lifted the pause on the J&J’s COVID-19 vaccine. CDC’s decision to lift the pause came following guidance from ACIP that said the benefits of the shot outweighed the risk of a rare blood clot. The vaccine label and fact sheets are being updated to reflect the risk. Moderna – has entered into an agreement with Sanofi to help manufacture as many as 200 million COVID-19 vaccine doses in the US. Sanofi will fill vials and finish packaging for Moderna at its facility in NJ. Astra Zeneca – The US will release 60 million doses for the AstraZeneca COVID-19 vaccine to other countries once it clears safety reviews by the FDA. The release will be over the next several months. Novavax – The two dose vaccine candidate has shown in clinical studies to be more than 89% effective in protecting against COVID-19 in its UK clinical trial. Doses are given one month apart and the vaccine only requires basic refrigeration. The company states that it will soon apply for authorization in the United States. MarkeTouch Media in the News Amber Specialty Pharmacy and MarkeTouch Media Release a Special Report on the Strategic Implementation of SMS/text and Voice Notifications Specialty pharmacy growth is outpacing traditional prescription medication growth encompassing nearly half of total US drug spend. The need for specialty pharmacies to develop a strategic communication plan for reaching, engaging, and managing patients has become an essential component for operational efficiency, clinical outcomes and customer satisfaction. Amber Specialty Pharmacy has partnered with Houston-based MarkeTouch Media to streamline their patient communication using automated, targeted, and responsive outbound notifications across a variety of services. This addition of using patient preferred communication has allowed Amber Specialty Pharmacy to provide more focus on their patients and spend less time managing routine tasks that were consuming valuable staff resources. Full results of the newly released whitepaper, “Five Immediate Benefits of Incorporating Specialty Pharmacy Focused Automated Outbound Patient Notifications” are available at the link below. Adam Winstead of Amber, said: “Amber Specialty Pharmacy has always taken a strategic approach leveraging technology to allow us to better serve our patients. With MarkeTouch Media’s TouchPoint Management solution, we saw improvements in: patient adherence, patient experience and overall satisfaction. Furthermore, we have seen effective improvements in clinical outcomes and operational efficiencies. Our partnership with MarkeTouch has been a catalyst in creating a more focused approach to assisting our patients.” Lyle Green, MarkeTouch Media’s Vice President of Sales and Marketing, commented, “Amber Specialty Pharmacy was growing rapidly and needed solutions to assist in managing the administrative and operational tasks to streamline workflow and benefit their patients. We are thrilled with the results that Amber is achieving and they clearly demonstrate that TouchPoint Management is a valuable tool for all Specialty Pharmacies.” Amber Specialty Pharmacy and MarkeTouch Media continue to collaborate and develop additional services specifically tailored to meet the needs of Specialty pharmacy patients. To take a deep dive into the white paper’s findings, click below. Five Immediate Benefits of Incorporating Specialty Pharmacy Focused Automated Outbound Patient Notifications
Specialty pharmacy growth is outpacing traditional prescription medication growth encompassing nearly half of total US drug spend. The need for specialty pharmacies to develop a strategic communication plan for reaching, engaging, and managing patients has become an essential component for operational efficiency, clinical outcomes, and customer satisfaction. Amber Specialty Pharmacy has partnered with Houston-based MarkeTouch Media to streamline their patient communication using automated, targeted, and responsive outbound notifications across a variety of services. This addition of using patient preferred communication has allowed Amber Specialty Pharmacy to provide more focus on their patients and spend less time managing routine tasks that were consuming valuable staff resources. Full results of the newly released whitepaper, “Five Immediate Benefits of Incorporating Specialty Pharmacy Focused Automated Outbound Patient Notifications”, can be read here. Adam Winstead of Amber said, “Amber Specialty Pharmacy has always taken a strategic approach leveraging technology to allow us to better serve our patients. With MarkeTouch Media’s TouchPoint Management solution, we saw improvements in patient adherence, patient experience, and overall satisfaction. Furthermore, we have seen effective improvements in clinical outcomes and operational efficiencies. Our partnership with MarkeTouch has been a catalyst in creating a more focused approach to assisting our patients.” Lyle Green, MarkeTouch Media’s Vice President of Sales and Marketing, commented, “Amber Specialty Pharmacy was growing rapidly and needed solutions to assist in managing the administrative and operational tasks to streamline workflow and benefit their patients. We are thrilled with the results that Amber is achieving, and they clearly demonstrate that TouchPoint Management is a valuable tool for all Specialty Pharmacies.” Amber Specialty Pharmacy and MarkeTouch Media continue to collaborate and develop additional services specifically tailored to meet the needs of Specialty pharmacy patients. To take a deep dive into the white paper’s findings, request a download of the PDF here. About Amber Pharmacy Amber Specialty Pharmacy is an award-winning leader in the specialty pharmacy industry with over 23 years of experience providing specialized care for persons with chronic, complex medical conditions. Named the National Association of Specialty Pharmacy’s 2020 Specialty Pharmacy of the Year, they have built an outstanding reputation by providing personalized support and quality clinical care to patients and families. This comprehensive care approach supports the medical, emotional, financial and administrative needs of patients throughout the United States. Amber Specialty Pharmacy is accredited by the Utilization Review Accreditation Commission (URAC) and the Accreditation Commission for Health Care (ACHC). Amber Specialty Pharmacy headquarters are located in Omaha, Nebraska, with an additional 20 locations throughout the United States. For more information, visit www.amberpharmacy.com About MarkeTouch Media MarkeTouch Media is a healthcare technology company committed to excellence in patient engagement. MarkeTouch provides our clients with patient communication solutions focused on improving clinical outcomes, operational efficiency and the patient experience. As a pioneer in automated outbound notifications in the healthcare space, MarkeTouch is celebrating its 20th anniversary in 2021. MarkeTouch provides almost 400 million annual patient communications on behalf of over 11,000 pharmacies across North America. The MarkeTouch difference is the unique combination of healthcare experience, communication expertise, innovative solutions, proven scalability, and reliability. For more information, visit www.marketouchmedia.com.
CDC Advisory Committee on Immunization Practices Recommends Extending the Pause on Administration of Johnson + Johnson Vaccine
According to the CDC, as of 3/30/2021, COVID-19 Vaccine Tracker, a total of 189 million doses have been delivered, 147 million doses have been administered. This accounts for 20.7% of the U.S. population over 18 years of age being fully vaccinated and 49.8% of the U.S. population over 65 years of age being fully vaccinated. Interesting stat: the highest daily reported total number of new daily COVID-19 cases in the U. S. occurred on January 8, 2021 – 315,119. On March 29, 2021 that number was reported as 60,699 new cases. mRNA Vaccines Highly Effective in Real World Situations Nearly 4,000 health care personnel, first responders, and other essential and frontline workers completed weekly SARS-CoV-2 testing for 13 consecutive weeks (HEROES-RECOVER Study). Under real-world conditions, mRNA vaccine (Pfizer and Moderna) effectiveness after full immunization (≥14 days after second dose) was 90% against SARS-CoV-2 infections whether symptomatic or not. Vaccine effectiveness of partial immunization (≥14 days after first dose but before second dose) was 80%. The results reinforce CDC’s recommendation of receiving full 2-dose immunizations for mRNA vaccines and COVID-19 vaccination is recommended for all eligible persons. Scruples and Drams – News and Notes from around Pharmacy and Healthcare Pfizer announced plans to develop other vaccines beyond COVID-19 using mRNA technology. By April 19, Americans will have access to COVID-19 vaccine in 40,000 pharmacies using the Federal Retail Pharmacy Program, up from the prior 17,000 included pharmacies. Retired pharmacists are among those approved to vaccinate against COVID-19 as the Public Readiness and Emergency Preparedness Act (PREP Act) has expanded its list of the people who can administer the vaccines. Reports from the White House suggest that there is no federal mandate for rolling out COVID vaccine passport systems, leaving the matter to the private sector. 46% of individuals who are open to getting a COVID-19 vaccination do not have a preference which one they get (Kaiser Family Foundation) Vaccine Updates Johnson + Johnson is back on track to meeting their 20 million vaccine dose delivery goal by the end of March. Pfizer has begun testing it’s COVID-19 vaccine in children 12 and under. Results from the clinical trial are expected in the second half of the year. The company plans to request emergency use authorization for 12 to 15 year-olds in the coming weeks. AstraZeneca released high-level results from their Phase III trial. Vaccine efficacy at preventing symptomatic COVID-19 was 76%, 15+ days after receiving two doses, four weeks apart. Vaccine efficacy for participants 65+ was 85%. Results demonstrated 100% efficacy for preventing severe/critical disease and hospitalization. Vaccine Hesitancy – Fewer people are saying they want to “wait and see” how the vaccine works in others before getting it themselves. 17% responded “wait and see” in the KFF March survey, dropping from 22% in February and 31% in January. Patient Care Corner – COVID-19 Vaccine Guidance for People Living with MS The MS Society has released guidance for receiving COVID-19 vaccinations for patients with Multiple Sclerosis. The MS Society reiterated that there is no preferred vaccine, the vaccines are safe to use with MS medications and that people with MS should be vaccinated. Specific guidance to a patient’s disease modifying therapy (DMT): Continue a DMT unless advised by your MS healthcare provider to stop or delay it. Some DMTs may make the vaccine less effective but it will still provide some protection. For those taking Kesimpta, Lemtrada, Ocrevus, or Rituxan consider coordinating the timing of your vaccine with the timing of your DMT dose. Work with a MS healthcare provider to determine the best schedule. Review the MS Society full considerations related to the timing MS medications with COVID-19 vaccines. Pregnant Women Show Robust Immune Response to COVID Vaccines, Pass Antibodies to Newborns In the largest study of its kind to date, researchers have found the new mRNA COVID-19 vaccines (Pfizer/BioNTech and Moderna) to be highly effective in producing antibodies against the SARS-CoV-2 virus in pregnant and lactating women. The results also demonstrated the vaccines confer protective immunity to newborns through breastmilk and the placenta. Researchers also compared vaccination induced antibody levels to those induced by natural COVID-19 infection during pregnancy, and found significantly higher levels of antibodies from vaccination. Lastly, vaccine-generated antibodies were also present in all umbilical cord blood and breastmilk samples taken from the study, showing the transfer of antibodies from mothers to newborns.
The US is currently vaccinating around 2.2 million patients a day. Almost 65% of Americans 65+ have received at least one dose of a COVID-19 vaccination.
The NACDS RxIMPACT program also recognized the seven Pioneers who participated in this year’s event. The Pioneers are those who attended the first NACDS RxIMPACT Day on Capitol Hill in 2009. The Pioneers who also participated in this year’s 13th Anniversary event included Rebecca Lichucki, MarkeTouch Director of Clinical Solutions.
Janssen COVID-19 Vaccine Receives EUA The FDA has issued emergency use authorization (EUA) for the Janssen (Johnson + Johnson) COVID-19 vaccine. The single dose (0.5 ml) injection is authorized use in individuals 18 years of age and up. The most commonly reported side effects were; pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects were mild to moderate in severity and appeared within 1-2 days, lasting the same 1-2 day timeframe. Storage of unpunctured multi-dose vials is at 2°C to 8°C (36°F to 46°F). The vaccine should be protected from light. Do not freeze the Janssen COVID-19 vaccine. Unpunctured vials of Janssen COVID-19 vaccine may be stored between 9°C to 25°C (47°F to 77°F) for up to 12 hours. After the first dose has been withdrawn from a vial, that vial can be kept between 2° to 8°C (36° to 46°F) for up to 6 hours or at room temperature (25°C / 77°F) for up to 2 hours. Discard the vial if the vaccine is not used within these times. Vaccine Updates Johnson + Johnson – A CDC epidemiologist said Monday that in the rare case where patients experience an allergic reaction to the first dose of either the Pfizer or Moderna (mRNA) vaccine they could use the Janssen vaccine, at least 28 days later, under the advise and supervision of their doctor. CDC guidance above. Novavax – A vaccine from Novavax could be available in the U.S. as early as May, according to their CEO, if the FDA allows data from a U.K. phase 3 trial that showed the shot had 89% efficacy. A phase 3 trial that includes 30,000 U.S. participants is ongoing. Moderna – has developed a booster COVID-19 vaccine that specifically targets the South Africa variant. Phase 1 clinical trials will begin soon. Pfizer – FDA agreed to allow the Pfizer-BioNTech vaccine to be transported and stored for up to two weeks at conventional temperatures typically found in pharmaceutical freezers. Should I Still Wear a Mask After Covid-19 Vaccination? Both the Pfizer-BioNTech and Moderna vaccine do not provide significant first dose immune protection until 12 – 14 days after the first dose and they only reach 51 – 52% efficacy after a few weeks, per a December study in The New England Journal of Medicine. During this antibody building period, the body is still relatively vulnerable to COVID-19 infection. People will also need to be thoughtful of if and when friends and family get vaccinated until researchers are sure about the risk of COVID-19 transmission post vaccination, and a large enough portion of the population is vaccinated to achieve herd immunity. Therefore, it is the widely held recommendation that we must continue to wear masks, practice social distancing and maintain good hygiene. CDC guidance is coming soon on safe activities for those who have received a full course of a COVID-19 vaccine.
How Does the Johnson & Johnson COVID-19 Vaccine Work? While each of the Pfizer, Moderna and Johnson & Johnson vaccines target the spike protein found on the surface of SARS-CoV-2, the Johnson and Johnson vaccine, manufactured by Janssen, uses a completely different technology. The Janssen vaccine is what’s called an adenovirus-vectored vaccine. The adenovirus acts as a sort of Trojan horse to deliver SARS-CoV-2 protein to the immune system. It cannot replicate or cause disease. Once injected, the adenovirus goes inside your cells and releases that SARS sequence. Your body then converts it into the spike proteins of SARS-CoV-2, minus the disease-causing virus. Then, your immune system learns to recognize the spike protein. Allowing your immune system to provide a faster, stronger defense next time it encounters the COVID-19 causing virus. Vaccine Updates Johnson & Johnson – the FDA set February 24th as the date, for the committee to review the Janssen, single dose, COVID-19 vaccine. They are expected to make a decision about an emergency use authorization (EUA) shortly after the meeting. Pfizer – on February 7th, Pfizer shared that it has doubled its output in the last month and will soon be able to cut the time it takes to produce a batch of vaccines from 110 days to 60 days on average. AstraZeneca – expects to have a modified version of its COVID-19 vaccine that will be effective against the South Africa variant by fall. AstraZeneca stated that the modified version would require less time and less clinical testing than the original. Moderna – is asking U.S. regulators to allow it to increase the amount of coronavirus vaccine put into each vial by as much as 50%, which they state can accelerate patient vaccine access. An FDA decision could take several weeks. Vaccinated Mothers May Pass on SARS-CoV-2 Antibodies to Newborns Pregnant women are of the designated high-risk groups requiring special protection from COVID-19. Researchers have been trying to determine if vaccinating pregnant women would produce protective antibodies that are capable of crossing the placenta reaching the fetus or newborn. A newly released study describes the first case of anti-SARS-CoV-2 antibodies detected in the cord blood of an infant born to a mother immunized with the first dose of the Moderna vaccine three weeks earlier. Data shows that detectable levels of IgG antibodies to the SARS-CoV-2 virus were found in the cord blood sample. While further research is needed, protection for babies of vaccinated moms may be possible. Ford Designs Clear Mask to Aid Hearing-Impaired Ford has developed, designed and is preparing to market a patent-pending, clear respirator in the hopes of benefitting those with hearing impairments. What makes the respirator mask unique is that it is transparent, low-cost and reusable. The goal is to permit people to communicate better by seeing the full range of human expression. For individuals with a hearing impairment, the clear mask would allow them to improve lip reading ability currently hidden by currently available personal protective equipment. Ford expects the respirator to certify to N95 standards of virus protection. Effectiveness testing is currently ongoing. Ford is hoping to make the product available later this spring. Do You Have a Solution in Place, Capable of Handling Massive COVID-19 Immunization Requests? Enter MarkeTouch’s Health and Wellness Scheduler. Currently managing millions of COVID-19 vaccine appointment inquires daily, the Health and Wellness Scheduler has been enhanced to allow pharmacies the ability to customize appointment availability. It also offers customizable mobile-optimized vaccine consent forms either as a stand alone service or incorporated into the patient appointment scheduling process. Contact MarkeTouch today to learn more about adding the convenience of appointment scheduling to your COVID-19 vaccination strategy.
MarkeTouch is proud to be your partner and resource for patient engagement. We hope you find this week’s COVID-19 Clinical & Operations Update useful. Thank you for all you do, take care.
MarkeTouch is proud to be your partner and resource for patient engagement. We hope you find this week’s COVID-19 Clinical & Operations Update useful.
Thank you for all you do, take care.
We understand this is a busy and challenging time. MarkeTouch is proud to be your partner and resource for patient engagement. Welcome to the COVID-19 Clinical & Operations Update, your quick reference to the latest COVID-19 news. We hope you find it helpful. Thank you & take care.
This month, MarkeTouch is pleased to introduce you to Matt Feltman, our Vice President of Clinical Services. Matt has been with MarkeTouch for 2 years. Q: What is the role of a VP of Clinical Services at MarkeTouch? A: It is one-part sales, one-part clinical, one-part development. I get to work with great clients, developing innovative, patient-centered programs and engaging with wonderful industry groups. Q: What has been your favorite project at MarkeTouch? A: Working on the patents related to our innovative services. Q: If you won the lottery, what is the first thing you would do? A: Hug Cindy, my wife, and then enjoy multiple bourbons. Q: When you have free time, how do you pass the time? A: I like to run, surf, kayak, and beach metal detect. Q: Favorite animal? A: Besides Zeus, our 7 pound yorkie mix, polar bears. Q: Biggest trend today? A: Maintaining camaraderie and connectedness during this time of “disconnectedness”. People need people and the more ways that we can find to relate to and stay connected with one another, I think, the happier and healthier we will be. Q: What is your favorite home-cooked meal? A: Roasted oysters, PBR, garlic cheese grits, and anything from my deep fryer. Q: What is your favorite ice cream flavor? A: Butter pecan. Q: Favorite line from a movie? A: From Rudy: “I wish God would put your heart in some of my players’ bodies.” Q: What is your favorite thing about working at MarkeTouch? A: Sounds cliché, but it’s truly being part of a team. A team that counts on each other to do what each individual does bet to reach our and our clients’ goals.
This month, MarkeTouch is pleased to introduce you to Charles Russo, our President and Chief Executive Officer. Charles has been with MarkeTouch for 20 years. Q: What would you name the autobiography of your life? A: Hard Work and a Lot of Luck. Q: Fill in the blank. I once met… A: Neil Armstrong. Q: Are you more productive in the mornings, afternoons, or evenings? A: Mornings, but not too early. Q: What was the first concert you attended? A: The Rolling Stones. Q: What is something you learned in the last week? A: Fly fishing. Q: What’s the coolest (or most important) trend you see today? A: For me, grandchildren. Q: What would you most like to tell yourself at age 13? A: You only get out what you put in. Don’t expect more until you do more. Q: What advice do you have for someone starting out in the tech space? A: Be as disciplined as possible to your plan, and don’t try to follow every trend. Q: How do you define success? A: Success is different for everyone and is better defined by the people you surround yourself with. Q: What’s your favorite sports team? A: The Houston Astros. Q: One thing you’re willing to spend more money on to make sure you get the best quality? A: I don’t buy a lot of things, but everything I buy, I’m willing to pay for quality. Q: What is your favorite thing about MarkeTouch? A: The amount of effort it has taken to get to this point and the co-workers who helped get us here.
This month, MarkeTouch is pleased to introduce you to Jason Love, our Senior Database Administrator. Jason has been with MarkeTouch for 4 years. Q: What has been your favorite project at MarkeTouch? A: Upgrading the production SQL servers is still at the top. Q: What is the most important trend you see today? A: Data security. Q: If you won the lottery, what is the first thing you would do? A: Build my very own pandemic-proof gym. Q: First place you will visit after COVID-19 travel opens up? A: The beaches of Mexico. Q: When you have 30 minutes of free time, how do you pass the time? A: Watching HGTV. Q: Favorite sports team? A: Go Astros!! Q: What is something you learned in the last week? A: How to be comfortable in a mask. Q: What chore do you absolutely hate doing? A: Bringing in the trash cans when it’s raining. Q: Favorite childhood TV show? A: Saved by the Bell. Q: What aspect of your role do you enjoy the most? A: I enjoy the responsibility for the integrity and security of our customer data. Q: What would you do for a career if you weren’t doing this? A: Peloton instructor. Q: What is your favorite thing about working at MarkeTouch? A: Working with a great team of professionals.
This month, MarkeTouch is pleased to introduce you to Kristy Horan, one of our Client Services Senior Account Managers. Kristy has been with MarkeTouch for 12 years. Q: What is a Senior Account Manager? A: I am my clients’ primary contact with MarkeTouch. It is my pleasure to grow, nurture, and manage my accounts on a day-to-day basis. Q: Favorite line from any show? A: “You miss 100% of the shots you don’t take. Wayne Gretzky.” Michael Scott. Q: If you could do another job for just one day, what would it be? A: I love to sing (although I probably shouldn’t), but I always thought it would be so much fun to sing in a band. Q: What did you want to be when you grew up? A: A writer. Q: What aspect of your role do you enjoy the most? A: Building relationships with my clients and helping them achieve their goals. Q: Where is your favorite place to eat? A: Brian’s BBQ. Q: Favorite travel spot? A: I’m kind of a homebody, but I would love to visit Ireland to learn more about my heritage. Q: If you could pay someone to do your least favorite chore, what would that be? A: Clean the litter box. Q: First thing you will do when the COVID-19 isolation is over? A: Go to HomeGoods and buy some new throw pillows.
We are disappointed that the AMCP 2020 Conference was cancelled as we were looking forward to meeting with you at our expo booth. However, we understand the unprescedented measures that are necessary to stop the spread of COVID-19. Most importantly, we hope that you are healthy. Just because AMCP isn’t happening this year, you can still: Increase formulary compliance Enhance clinical program support Lower drug spend Improve member outcomes Lift client and member satisfaction MarkeTouch hosted webinars in April. If you missed the webinar this year, click here to see a 45-minute recording of one of the sessions!
MEMPHIS, Tenn., Aug. 28, 2017 /PRNewswire/ — fred’s Pharmacy customers now have more ways to save money at fred’s stores. Today fred’s launched digital coupons along with a new mobile app that makes using digital coupons easy and convenient. Hundreds of digital coupons will be available, including favorite brand-name products with discounts over and above fred’s everyday low prices. Customers will also save money with exclusive deals on brand-name and fred’s-brand products, buy-one-get-one free offers, and other great savings. To take advantage of these deals, customers can easily create an account at fredsinc.com/coupons, or download the new fred’s mobile app and clip/save digital coupons to their account. To offer even more convenience, fred’s Pharmacy does not require a loyalty card to redeem digital coupons; customers simply enter their phone number at checkout to save. The fred’s Pharmacy mobile app is available for free on Android and iOS devices. The app presents coupons and discounts in a gallery, sortable by brand or category. Customers can also view the current ad, where items that have a digital coupon are indicated, and the coupon can be saved directly from the ad to the customer’s account. When shopping at fred’s, customers can search for coupons on the spot and clip and redeem them instantly, because there is no lag time between when a coupon is clipped and when it’s available to use. “It’s important to us that we provide the best value to our customers on the products they love, and now they can save hundreds of dollars more using digital coupons,” said Mary Lou Gardner, Executive Vice President, Chief Merchandising & Marketing Officer, fred’s Inc. “Plus, we designed the process to be as quick and easy as possible, and the new mobile app adds even more convenience by putting deals in customers’ hands right in the store.” “We worked to ensure our customers have the best-possible experience with our digital coupons. This is the kind of value-rich, shopper-friendly program that our customers have come to expect from fred’s, and we want it to operate seamlessly,” Gardner added. Additional features available on the fred’s Pharmacy mobile app include user-friendly prescription management tools. Tools providing prescription information, quick fill and refill, a symptom checker, and more are designed to help customers easily manage prescriptions for their whole family. About fred’s Inc. Tracing its history back to an original store in Coldwater, Mississippi, opened in 1947, today fred’s Pharmacy is headquartered in Memphis, Tennessee, and operates 601 pharmacy and general merchandise stores and three specialty pharmacy-only locations, including 14 franchised fred’s Pharmacy locations. With a unique store format and strategy that combines the best elements of a healthcare-focused drug store with a value-focused retailer, fred’s Pharmacy stores offer more than 12,000 frequently purchased items that address the healthcare and everyday needs of its customers and patients. This includes nationally recognized brands, proprietary fred’s Pharmacy label products, and a full range of value-priced selections. The company has two distribution centers, one in Memphis, Tennessee, and Dublin, Georgia. For more information about fred’s Pharmacy, visit www.fredsinc.com. SOURCE fred’s Pharmacy
Recent years have brought unprecedented challenges to the practice of pharmacy. Today, pharmacies are seeing lower profit-per-script from mushrooming generic use and lower margins from the proliferation of closed and limited networks. In anticipation of these and other challenges, MarkeTouch Media has invested heavily in developing truly innovative technology solutions, expanding its platform from custom patient communications to become a full-service clinical provider. MarkeTouch Media’s Clinical Intervention Suite is a robust, fully customizable engine that empowers pharmacists to have targeted clinical conversations with patients while easing workflow burden on pharmacy staff. It includes multiple modules that enable client pharmacies to target and manage specific patient populations while maximizing contract incentives and minimizing penalties. MarkeTouch Media first analyzes the entire patient population, calculates PDC and a proprietary adherence score, notes whether immunizations or other services are needed, and then provides the list of clients to target for interventions, helping the pharmacy meet its contract objectives. Solutions targeted at DIR incentives focus on PDC scores across the entire Payor by drug class, while specialty pharmacy modules focus on patient assessments and data at intervals specific to each drug or disease state. MarkeTouch’s staff applies industry-leading expertise and best practices to effectively deploy clinical programs designed to meet clients’ goals and metrics. In addition, MarkeTouch’s capabilities and scale (a network of more than 15,000 retail pharmacies) enable it to readily run customized pilots for its clients, who can see for themselves the efficacy of the technology in driving down healthcare costs. For instance, MarkeTouch Adherence Interventions could increase PDC scores of targeted drug classes by more than 30 percent in 180 days by identifying and addressing barriers to adherence in retail pharmacy environments. MarkeTouch Media’s RxTouch Pharmacist Connect is a fully hosted solution that streamlines pharmacy operations and allows each patient to choose preferred communication channels for pharmacy interaction. By employing the patients’ channel preferences, the pharmacy can achieve greater adherence and persistency to the prescribed regimen. Each client can select campaigns that ensure targeted patients make a positive impact on quality and operational metrics—resulting in a maximized ROI, reduced overall healthcare costs and, ultimately, better clinical outcomes for patients.